Owned by the Association for International Promotion & Study in Tumors (APSIT)
SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis
Aberrant alternative splicing (AS) is a pervasive event during colorectal cancer (CRC) development. SF3B3 is a splicing factor component of U2 small nuclear ribonucleoproteins which are crucial for early stage...